Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 527.50
Bid: 529.00
Ask: 531.50
Change: 12.00 (2.33%)
Spread: 2.50 (0.473%)
Open: 517.50
High: 534.50
Low: 517.50
Prev. Close: 515.50
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New ESG RCF and Financing Update

19 Nov 2020 07:00

RNS Number : 8002F
Drax Group PLC
19 November 2020
 

19 November 2020

Drax Group plc

("Drax", the "Group" or the "Company"; Symbol: DRX)

 

New ESG RCF and Financing Update

 

New Environmental, Social and Governance (ESG) Revolving Credit Facility (RCF)

Drax is pleased to announce that it has completed the refinancing of its revolving credit facility.

 

The new £300 million facility ("the Facility") matures in 2025, with an option to extend by one year(1). The Facility replaces the current RCF which matures in 2021 and provides increased liquidity, enabling the full facility to be drawn as cash (the previous facility restricted cash drawn to support liquidity to £165 million). The Facility is currently undrawn for cash.

 

The Facility has a customary margin grid referenced over LIBOR, which reflects a small reduction in cost versus the current RCF and includes an embedded ESG component which adjusts the margin based on Drax's carbon intensity measured against an annual benchmark.

 

Drax has also agreed a change to the Group's £35 million term-loan facility, maturing in 2022, in order to simplify its capital structure. This facility will now rank as senior, previously super senior.

 

Drawing of previously agreed infrastructure facility

On 14 September 2020, Drax confirmed that it had agreed a new infrastructure term-loan agreement (the "Agreement") that provided committed facilities of approximately £160 million with a range of maturities between 2024 and 2030(2). These facilities extended the Group's maturity profile while also reducing the cost of debt. Drax has now drawn £28 million(2), with the balance to be drawn by February 2021.

 

The Agreement also included an option for a further £75 million. Under this option Drax has now agreed £53 million maturing in 2028, which will be drawn in December 2020.

 

Proceeds from Euro denominated bond issue and utilisation

On 4 November 2020, Drax issued €250 million of Euro denominated senior secured notes which mature in 2025. The effective Sterling-equivalent interest rate is 3.24% per annum.

 

The proceeds from this issuance, along with existing cash flows, are being used to redeem the Group's £350 million 2022 Sterling bond and £125 million ESG term-loan facility.

 

The notes extend the Group's debt maturity profile and reduce the overall cost of debt to approximately 3.7%.

 

Summary of Group debt structure at 19 November 2020

 

Instrument

Maturity

Description

Infrastructure facilities (2019)

 

Infrastructure facilities (Sept 2020)

 

Infrastructure facilities (Nov 2020)

 

2024-2029

 

2024-2030

 

2028

£375m

 

approx.£160m(2) (£28m(2) drawn)

 

£53m

Bonds

 

2025

 

2025

 

$500m

 

€250m

RCF

2025

 

£300m (undrawn for cash)

Index-linked term-loan

2022

 

£35m

 

Enquiries:

Drax Investor Relations: Mark Strafford

+44 (0) 7730 763 949

 

Media:

Drax External Communications: Selina Williams

+44 (0) 7912 230 393

 

Website: www.drax.com

 

END

 

Note

(1) Subject to lender consent.

(2) Approximately £160m - €25 million in 2024, €70 million in 2026, £45 million in 2027 and €31.5 million (£28 million) in 2030. To date Drax has only drawn €31.5 million (£28 million) with the balance to be drawn by February 2021. Drax intends that foreign exchange hedging of Euro denominated proceeds will take place prior to the drawdown of funds.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGBDBUSBDGGI
Date   Source Headline
2nd May 20244:21 pmRNSPartial cancellation of senior secured notes
2nd May 20243:19 pmRNSHolding(s) in Company
2nd May 20243:12 pmRNSTotal Voting Rights
1st May 20241:51 pmRNSHolding(s) in Company
30th Apr 20243:17 pmRNSHolding(s) in Company
30th Apr 20243:08 pmRNSHolding(s) in Company
25th Apr 20242:01 pmRNSResult of AGM
25th Apr 20247:00 amRNSTrading Update
24th Apr 20243:33 pmRNSHolding(s) in Company
23rd Apr 202410:34 amRNSHolding(s) in Company
19th Apr 202410:32 amRNSNotice of Redemption
18th Apr 20245:01 pmRNSPricing of offering of Senior Secured Notes
17th Apr 20249:00 amRNSDirector/PDMR Shareholding
16th Apr 202410:54 amRNSFixed income investor calls
15th Apr 20249:35 amRNSHolding(s) in Company
8th Apr 20244:54 pmRNSHolding(s) in Company
5th Apr 20243:48 pmRNSBlock listing Interim Review
5th Apr 20243:47 pmRNSBlock listing Interim Review
5th Apr 20243:42 pmRNSBlock listing Interim Review
5th Apr 20248:00 amRNSDirector/PDMR Shareholding
4th Apr 20245:11 pmRNSHolding(s) in Company
4th Apr 202410:18 amRNSTotal Voting Rights
4th Apr 20247:00 amRNSNew £150 million term-loan facility
3rd Apr 202410:15 amRNSHolding(s) in Company
28th Mar 20243:05 pmRNSHolding(s) in Company
25th Mar 20243:48 pmRNSHolding(s) in Company
25th Mar 20248:45 amRNSAdditional Listing
22nd Mar 202410:54 amRNSHolding(s) in Company
21st Mar 20248:00 amRNSMailing of Annual Report and Notice of AGM
18th Mar 20242:04 pmRNSHolding(s) in Company
18th Mar 202410:30 amRNSDirector/PDMR Shareholding
15th Mar 20242:51 pmRNSHolding(s) in Company
14th Mar 20241:37 pmRNSHolding(s) in Company
11th Mar 202412:26 pmRNSHolding(s) in Company
8th Mar 20244:07 pmRNSHolding(s) in Company
6th Mar 20242:46 pmRNSHolding(s) in Company
4th Mar 20243:35 pmRNSTotal Voting Rights
4th Mar 20243:18 pmRNSHolding(s) in Company
1st Mar 20242:38 pmRNSHolding(s) in Company
29th Feb 20247:04 amRNSNon-Executive Director standing down
29th Feb 20247:00 amRNSAnnual Financial Report
28th Feb 20247:00 amRNSCapacity Market Agreements
27th Feb 20249:20 amRNSHolding(s) in Company
23rd Feb 20244:32 pmRNSHolding(s) in Company
22nd Feb 202412:46 pmRNSNotice of Results
21st Feb 20249:32 amRNSHolding(s) in Company
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.